Hand-held electric hair dryers.

Pharmaceutical preparations, namely, human pharmaceuticals for the treatment of cancers, cardiovascular diseases, diabetes, hypertension, vascular diseases, pulmonary and bronchoconstrictive diseases and conditions, gastrointestinal disorders, diseases and conditions associated with cardiac muscle, and/or skeletal muscle dysfunction, wasting, atrophy or weakness; human pharmaceuticals for the treatment of neurological, metabolic, musculoskeletal, and neuromuscular diseases and conditions, namely, (i) muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely, muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia; (ii) muscle dysfunction originating from neuronal dysfunction or transmission, namely amyotrophic lateral sclerosis, spinal muscular atrophies, hereditary ataxias, hereditary motor and sensory neuropathies, hereditary paraplegias, stroke, multiple sclerosis, brain injuries with motor deficits, spinal cord injuries, Alzheimer's disease, Parkinson's disease with motor deficits, myasthenia gravis and Lambert-Eaton syndrome.

Technical consulting and research in the field of cellular assay screening, pharmaceutical discovery and development, and patient diagnosis.

Pharmaceutical and veterinary preparations, namely, human and veterinary pharmaceuticals for the treatment of cancers, cardiovascular diseases, diabetes, hypertension, vascular diseases, pulmonary and bronchoconstrictive diseases and conditions, gastrointestinal disorders, diseases and conditions associated with cardiac muscle, smooth muscle and/or skeletal muscle dysfunction, wasting, atrophy or weakness, ophthalmologic diseases, and diseases and conditions associated with dysfunction of non-muscle myosin; human and veterinary pharmaceuticals for the treatment of neurological, metabolic, musculoskeletal, and neuromuscular diseases and conditions, namely, (i) muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia; (ii) muscle dysfunction originating from neuronal dysfunction or transmission, namely amyotrophic lateral sclerosis, spinal muscular atrophies, hereditary ataxias, hereditary motor and sensory neuropathies, hereditary paraplegias, stroke, multiple sclerosis, brain injuries with motor deficits, spinal cord injuries, Alzheimer's disease, Parkinson's disease with motor deficits, myasthenia gravis and Lambert-Eaton syndrome; and (iii) CNS, spinal cord or muscle dysfunction originating from endocrine and/or metabolic dysregulation, namely claudication secondary to peripheral artery disease, hypothyrodism, hyper- or hypo-parathyroidism, diabetes, adrenal dysfunction, pituitary dysfunction and acid/base imbalances.

Human pharmaceuticals for the treatment of diseases and conditions associated with cardiac muscle, smooth muscle and/or skeletal muscle dysfunction, wasting, atrophy or weakness; human pharmaceuticals for the treatment of neurological, musculoskeletal, and neuromuscular diseases and conditions, namely, (i) muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia; (ii) muscle dysfunction originating from neuronal dysfunction or transmission, namely amyotrophic lateral sclerosis, spinal muscular atrophies, hereditary ataxias, hereditary motor and sensory neuropathies, hereditary paraplegias, stroke, multiple sclerosis, brain injuries with motor deficits, spinal cord injuries, Alzheimer's disease, Parkinson's disease with motor deficits, myasthenia gravis and Lambert-Eaton syndrome; and (iii) CNS, spinal cord or muscle dysfunction originating from endocrine and/or metabolic dysregulation, namely claudication secondary to peripheral artery disease, hypothyrodism, hyper- or hypo-parathyroidism, diabetes, adrenal dysfunction, pituitary dysfunction and acid/base imbalances.

Cooking plates and pans.

Software for web access to digital files, namely software for hosting a web-accessible digital file storage facility and for providing authenticated access to the digital files stored therein.

Web-based digital file storage services namely hosting a web-accessible digital file storage facility and providing authenticated access to the digital files stored therein.

Remotely controlled machines, which are motorized and mobile and such machines with manipulators, all for use in the mining industry and in manufacturing industries, the latter being production facilities where mechanical actions are performed that are amenable to work done by motorized, mobile robot like devices and where such facilities are typically assembly plants, chemical and hazardous substances production plants and production facilities that are remote or for other reasons not readily accessible for humans; autonomous machines, which are motorized and mobile and such machines with manipulators, all for use in the mining industry and in manufacturing industries, the latter being production facilities where mechanical actions are performed that are amenable to work done by motorized, mobile robot like devices and where such facilities are typically assembly plants, chemical and hazardous substances production plants and production facilities that are remote or for other reasons not readily accessible for humans; machine tools for use in the aforementioned industries and for use in workshop and factory shop floor tasks, in the aforementioned industries; industrial robots for the control and operation of machine tools, plant equipment and for shop floor tasks in the aforementioned industries.

Pharmaceutical preparations for the treatment of hyperlipidemia, agents affecting digestive organs namely, gastrointestinal cleaning agents, clysters (enemas), purgatives (evacuants), stomachics/digestives, mouth cavity cleansers, breath refreshers, emetics, antacids, antidiarrheals, anti-emetics, castor oil for medical purposes, tooth prophylactics and choleretics.

Computer controlled variable energy delivery system, namely, an electric motor, generator, electronic circuitry, throttle control and computer, sold as a conversion kit for bicycles, for monitoring, controlling and providing of locomotion energy to bicycles proportional to user demands, and for charging a battery when brake input is provided.

Programme d'ordinateur destiné à gérer les loyers d'immeubles résidentiels, subventionnés ou non, de condos ou d'établissements commerciaux. Toutes les activités telles la perception des loyers, l'enregistrement des baux ou contrats, l'envoi de correspondance aux occupants et la production de rapports de comptabilité sont intégrées dans un seul ensemble. Des outils de contrôle veillent à détecter les erreurs de l'utilisateur. Fonctionne sur les plateformes Windows et Mac OSX.